Middle East and Africa Pediatric Healthcare Market Size was valued at USD 47.91 Billion in 2023. The Pediatric Healthcare market industry is projected to grow from USD 50.01 Billion in 2024 to USD 67.62 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.84% during the forecast period (2024 - 2032). Population grows, increasing costs for healthcare, expanding knowledge and instruction, technological progress, disease incidence, are the key market drivers enhancing the market growth.
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
In January 2024, COPE Health Solutions is on the brink of establishing its inaugural pediatric COPE Health Scholars Program in collaboration with Children's Hospital of Orange County (CHOC), a pediatric healthcare system located in Southern California. The COPE Health Scholars programs are experiential educational and career ladder programs that provide students and community members with educational and training opportunities to advance their careers in healthcare.. The program provides direct patient care and prepares the scholars with a career development pathway by offering clinical and administrative rotations with nurses, doctors, other care team members, and administrators. CHOC will be the first pediatric health site in the country to offer this innovative program when it launches in January 2024. The COPE Health Scholar program is intended for high school graduates, college students, and career changers. It comprises online coursework, a minimum of 280 hours of in-person experience at CHOC, and access to the most suitable training and employment opportunities. Through the Health Scholar program, COPE Health Solutions has a longstanding commitment to providing high-quality experiential education that is directly linked to targeted career training and employment placement, thereby enhancing the quality, diversity, and accessibility of the health care workforce. This program provides a fully immersive experience that includes training and employment opportunities to work across a broad spectrum of healthcare, which is of interest to many of our current Scholars and alumni who are interested in pursuing careers in pediatrics.
Apollo, an integrated healthcare provider, has implemented an industry-first pediatric ProHealth Programme in July 2023 to address the growing prevalence of non-communicable diseases (NCDs) among children and adolescents. The Pediatric ProHealth Programme is initiated by Apollo to combat the increasing prevalence of non-communicable diseases in minors. The program conducts routine screenings and customizes tests based on family history and age. Apollo Children's operates 40 hospitals, has more than 900 dedicated beds, and employs 400 specialized pediatricians who offer specialized services in more than 25 specialized care specialties. With the objective of establishing a state-of-the-art, dedicated network to redefine pediatric healthcare. Apollo Children's will provide specialized interventions for a variety of complex medical and surgical paediatric conditions, such as congenital disorders, gastrointestinal and liver disorders, neurodevelopmental disorders, cardiac conditions, renal disease, oncology, and liver transplanting. A dedicated emergency department will be staffed by specialists and equipped with advanced life-saving apparatus as a component of their 24/7 paediatric emergency and intensive care services, ensuring the immediate and efficient management of emergencies.
The pediatric healthcare market in the Middle East and Africa (MEA) is a vibrant and quickly expanding industry that caters to the medical requirements of children in the area. It includes a wide range of medical services, such as screening, diagnosis, treatment, and specialised care for newborns, kids, and teenagers. Due to high birth rates and an expanding healthcare system, the MEA region has a sizable and growing population of youngsters. There is a considerable demand for pediatric healthcare services thanks to this expanding population. Governments in the area have been raising their healthcare spending to keep up with the rising demand because they understand how important it is to invest in healthcare, notably pediatric healthcare. The growing awareness and knowledge regarding children's heath is one of the major factors driving the MEA pediatric healthcare industry. Early childhood healthcare is important, and more and more parents and carers are seeking high-quality medical treatment for their kids. Due to the increase in demand for pediatric healthcare services, healthcare providers have been forced to expand their selections. Additionally, the development of the pediatric healthcare market in the MEA region has been significantly influenced by technological improvements. The diagnosis and treatment of pediatric disorders have been enhanced by new diagnostic techniques, cutting-edge medical procedures, and telemedicine options. These technology developments have boosted access to specialised care in far-flung and neglected locations while also improving healthcare results.
Pediatric health issues in the MEA region include chronic illnesses, malnutrition, and infectious diseases. The need for pediatric healthcare services has increased as a result of the incidence of these disorders. The region's governments have adopted a number of health-related measures, like as immunisation programmes and nutrition campaigns, which have helped the pediatric healthcare industry expand. The MEA pediatric healthcare market is expanding in large part due to medical tourism. For specialised pediatric treatments, nations like the UAE and South Africa have become major destinations for medical tourism. The expansion of pediatric healthcare facilities and services in these nations has been sparked by this influx of patients. Another important feature of the MEA pediatric healthcare industry is private sector participation. Private healthcare providers have made large investments in the area, enhancing healthcare infrastructure, providing cutting-edge therapies, and enhancing children's access to high-quality care. Thus, driving the Pediatric Healthcare market revenue.
The Middle East and Africa Pediatric Healthcare market segmentation, based on type of diseases includes short term diseases, chronic diseases and others. The short term diseases segment dominated the market, accounting for 41.2% of market revenue. Children are more likely than adults to contract short-term illnesses because of their immature immune systems and intimate social relationships in the community and at school.
The Middle East and Africa Pediatric Healthcare market segmentation, based on therapeutics, includes cardiology, allergy and immunology, gastroenterology, infectious disease and others. The infectious disease category generated the most income (37.2%). Pathogens like bacteria, viruses, fungi, and parasites are responsible for infectious diseases, which can harm a child's many organ systems.
The Middle East and Africa Pediatric Healthcare market segmentation, based on treatment includes medication, surgery and others. The medication segment dominated the market, accounting for 59.2% of market revenue. The administration of pharmacological medications to treat and manage pediatric diseases is a major component of pediatric healthcare.
Figure 1 Middle East and Africa Pediatric Healthcare Market, by Treatment, 2022 & 2032 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The GCC Countries Pediatric Healthcare Market dominated this market in 2022 (45.80%). The development and expansion of pediatric healthcare services in the UAE is facilitated by the availability of specialised facilities, knowledgeable medical personnel, and a dedication to healthcare innovation.
Figure 2 MIDDLE EAST AND AFRICA PEDIATRIC HEALTHCARE MARKET SHARE BY REGION 2022 (USD Billion)
Source Secondary Research, Primary Research, MRFR Database and Analyst Review
South Africa Pediatric Healthcare market accounts for the second-largest market share. This is due to the numerous top-notch hospitals and medical hubs in the area are outfitted with cutting-edge equipment and facilities to deliver complete pediatric healthcare services.
The Rest of MEA Pediatric Healthcare Market is expected to grow at the fastest CAGR from 2024 to 2032. Pediatric healthcare services are anticipated to advance due to initiatives to increase accessibility to healthcare, improve the healthcare staff, and use technology.
Pediatric Healthcare Key Market Players & Competitive Insights
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Pediatric Healthcare market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their Middle East and Africa footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Pediatric Healthcare industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Middle East and Africa Pediatric Healthcare industry to benefit clients and increase the market sector. In recent years, the Pediatric Healthcare industry has offered some of the most significant advantages to medicine. Major players in the Pediatric Healthcare market, including Novartis AG (Switzerland), AstraZeneca (UK), Janssen Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE), and others, are attempting to increase market demand by investing in research and development operations.
Novartis AG, headquartered in Switzerland, is a major player in the Middle East and Africa (MEA) pediatric healthcare sector and a major worldwide pharmaceutical firm. Novartis focuses on creating cutting-edge medical treatments for a range of pediatric health issues. Novartis is dedicated to enhancing pediatric healthcare in the MEA region by providing a selection of medication made especially for kids. The business makes research and development investments to create secure and efficient solutions for pediatric illnesses. In order to improve access to pediatric healthcare and promote illness prevention and management, Novartis also works with healthcare providers, governments, and nonprofit organizations.
AstraZeneca, a leading pharmaceutical company headquartered in the UK. The company focuses on creating and offering cutting-edge drugs and therapies for a range of pediatric health issues. Across order to improve pediatric healthcare access and results, AstraZeneca collaborates with healthcare providers, governments, and non-profit organisations across the MEA area. The business makes investments in research and development to address the distinct healthcare requirements of children in the area, creating drugs and therapies that are suitable for pediatric patients and are both secure and efficient. The dedication of AstraZeneca to pediatric healthcare goes beyond drug development. In order to enhance pediatric health outcomes in the MEA region, the company actively supports collaborations, educational programmers, and campaigns that raise awareness of diseases. AstraZeneca aims to improve disease prevention, early diagnosis, and suitable treatment options for kids across the Middle East and Africa by collaborating closely with healthcare stakeholders.
Key Companies in the Pediatric Healthcare market include
Pediatric Healthcare Industry Developments
May 2018 Gilenya (fingolimod), manufactured by Novartis AG, is the first disease-modifying drug approved for the treatment of children and adolescents with relapsing forms of multiple sclerosis (RMS), according to the US Food and Drug Administration (FDA).
| Report Attribute/Metric | Details |
| Market Size 2023 | USD 47.91 Billion |
| Market Size 2024 | USD 50.01Billion |
| Market Size 2032 | USD 67.62 Billion |
| Compound Annual Growth Rate (CAGR) | 3.84% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type of Diseases, Therapeutics, Treatment, and Region |
| Geographies Covered | Middle East and Africa |
| Countries Covered | GCC Countries, South Africa and Rest of MEA |
| Key Companies Profiled | Novartis AG (Switzerland), AstraZeneca (UK), Janssen Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE) |
| Key Market Opportunities | Partnerships and Alliance |
| Key Market Dynamics | Concentrate on Immunisation and Disease Prevention |
Pediatric Healthcare Market Highlights:
Frequently Asked Questions (FAQ) :
The Middle East and Africa Pediatric Healthcare market size was valued at USD 47.91 Billion in 2023.
The Middle East and Africa market is projected to grow at a CAGR of 3.84% during the forecast period, 2024-2032.
The key players in the market are Novartis AG (Switzerland), AstraZeneca (UK), Janssen Services, LLC (Belgium), Eli Lilly and Company (US), Bristol-Myers Squibb Company (US), AMMT (Dubai), King Faisal Specialist Hospital and Research Centre (Saudi Arabia), VPS Healthcare (UAE).
The Infectious Disease category dominated the market in 2023.
The Medication had the largest share in the Middle East and Africa market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
